Mina Therapeutics

Provider of RNA activation therapeutics

placeLondon, England, United Kingdom calendar_todayFounded 2008 groups18 employees language minatx.com

Registered entities

Innovation

32 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 7,198 times.

YearFilings
20154
20165
20176
20185
20198
202010
202110
202211
20239
202414
20252
20261

Investor mix

19 investors on record; lead investors include aMoon, Nxera, Boehringer Ingelheim.

Investor typeCountShare
Venture capital526%
Bank & private debt211%
Other / undisclosed1263%
Coming soon